期刊文献+

经尿道针状电极膀胱肿瘤剜除术治疗非浸润性膀胱癌的疗效分析 被引量:2

Clinical efficacy of en bloc transurethral resection of bladder tumor for non-muscle invasive bladder cancer
下载PDF
导出
摘要 目的:研究经尿道膀胱肿瘤剜除术的安全性及有效性,并分析影响非浸润性膀胱癌复发的因素。方法:选取70例非浸润性膀胱癌患者,随机分为经尿道膀胱肿瘤切除术组(transurethral resection of bladder tumor,TURBT)和经尿道针状电极膀胱肿瘤整块剜除术组(en bloc resection of bladder tumor,ERBT),每组35例患者,比较两组患者的手术时间、术后住院时间、发生闭孔反射情况、膀胱冲洗时间、留置导尿管时间及术后复发情况,并对所得数据进行统计学分析。结果:两组手术时间、术后住院时间及发生闭孔反射情况比较存在统计学差异,在术后患者膀胱冲洗的时间及留置导尿的时间方面无统计学差异。通过分析影响术后复发的因素,我们发现肿瘤大小、年龄及肿瘤病理分级比较具有统计学意义,而手术方式、手术时间、膀胱冲洗时间、留置尿管时间及年龄比较无统计学意义。通过对影响复发的多因素logistic回归分析,结果显示年龄和病理组织分级是影响患者复发的因素。结论:ERBT是一种治疗非浸润性膀胱癌安全有效的术式,值得临床推广。 Objective:To evaluate the safety and efficacy of en bloc resection of bladder tumor,and to analyze the factors influencing the recurrence of non-invasive bladder cancer.Methods:70 patients with non-muscle invasive bladder cancer were divided into 35 patients who were treated with en bloc resection of bladder tumor(ERBT)and 35 patients who were treated with transurethral resection of bladder tumor(TURBT).The operation time,postoperative hospitalization time,obturator reflex,bladder irrigation time,indwelling catheter time and postoperative recurrence were compared between the two groups,and the data were statistically analyzed.Results:There were statistical differences in operation time,postoperative hospital time and obturator reflex between the two groups,and there was no significant difference in bladder irrigation time and indwelling catheter time.By analyzing the factors of postoperative recurrence,we found that the size,age and pathological grade of the tumor were statistically significant,but the operation methods,operation time,bladder irrigation time,indwelling time and age were not statistically significant.The results of multiple logistic regression analysis showed that age and pathological grade were the factors influencing the recurrence.Conclusion:En bloc resection of bladder tumor is a safe and effective method for the treatment of non-invasive bladder cancer.
作者 佟昕 肖荆 陈美元 韩威 王翔宇 阮极盟 田野 TONG Xin;XIAO Jing;CHEN Meiyuan;HAN Wei;WANG Xiangyu;RUAN Jimeng;TIAN Ye(Department of Urology,Beijing Friendship Hospital,Capital Medical University,Beijing 100032,China)
出处 《现代肿瘤医学》 CAS 北大核心 2022年第24期4518-4521,共4页 Journal of Modern Oncology
关键词 经尿道针状电极膀胱肿瘤剜除术 非浸润性膀胱癌膀胱 复发 en bloc resection of bladder tumor non-muscleinvasive bladder cancer recurrence
  • 相关文献

参考文献3

二级参考文献54

  • 1张杰敏,阮萍,谢庆环,邢立花,卢金凤.膀胱灌注药物预防膀胱癌术后复发的护理[J].护理研究(下旬版),2005,19(9):1955-1956. 被引量:8
  • 2马云波,吕家驹.卡介苗加吡柔比星膀胱灌注预防膀胱肿瘤复发的效果观察及尿中IL-8变化的研究[J].中华泌尿外科杂志,2006,27(10):713-714. 被引量:24
  • 3Lamm DL. Prophylaxis for recurrent transitional cell carcinoma [J]. Urology, 1991,37(5 Suppl) :21-23.
  • 4McCabe RP, Lamm DL, Haspel MV, et al. A diagnostic-prognos- tic test for bladder cancer using a monoclonal antibody-based en- zyme-linked immunoassay for detection of urinary fibrin (ogen) deg- radation products [ J ]. Cancer Res, 1984,44 (12 Pt 1 ) :5886- 5893.
  • 5Garcia JA, Dreicer R. Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies[ J]. Nat Clin Pract Ural, 2005,2( 1 ) :32-37.
  • 6Nakagawa S, Kojin a M, Takada H, et al. Short-duration bladder instination therapy with piranibicin for superficial bladder tumor based on pharnacodynami cstudy [ J ] . Gan To Kagaku Ryoho, 1992,19( 11 ) :1873-1877.
  • 7Yamamoto Y, Nasu Y, Saika T, et al. The absorption of piran- bioninstilled intravesically immediately after transurethral resection of superficial bladder cancer [ J ]. BJU Int, 2000,86 ( 7 ) : 802- 804.
  • 8Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014 [J]. CACancerJClin, 2014, 64(1): 9-29.
  • 9Lenis A T, Chamie K. Bladder cancer in 2014: From the genomic frontier to immunotherapeutics[J]. Nat Rev Urol, 2015, 12(2): 74-76.
  • 10Chamie K, Litwin M S, Bassett J C, et al. Recurrence of high-risk bladder cancer: a population-based analysis [J]. Cancer, 2013, 119(17): 3219-3227.

共引文献103

同被引文献40

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部